Fischer Medical Ventures and Nervotec collaborate globally to enable haemoglobin, blood pressure, and HbA1C screening through camera- enabled device

Fischer Medical Ventures Limited, via its subsidiary Time Medical International Ventures (India) Private Limited, has partnered with Singapore-based Nervotec Pte Ltd to revolutionize healthcare screening with contactless video-based vital signs monitoring.

Fischer Medical Ventures Limited (Fischer MVL) is a pioneer in manufacturing high-quality MRI systems in India and offers a diverse range of diagnostic solutions. Nervotec’s innovative contactless health screening technology, using remote photoplethysmography (rPPG) and AI, measures vital signs such as heart rate, respiration rate, oxygen saturation, stress scores, and blood pressure through any camera-enabled device. Clinically validated in Singapore, Nervotec's solution is fast, accurate, and cost-effective, facilitating large-scale screening and early intervention.

Recently, Nervotec achieved a breakthrough by incorporating hemoglobin and HbA1C measurements into its contactless technology, delivering quick results without blood samples. This strategic partnership combines Fischer MVL's expertise and global reach with Nervotec's cutting-edge technologies to redefine healthcare delivery worldwide.